News of the layoffs come just one day after the company reported a 5% year over year revenue increase — boosting revenue to ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

The BioSecure Act seeks to reduce US-China biotech ties, creating potential for India to become a biomanufacturing hub.

Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Arvinas Inc. (NASDAQ:ARVN), a biotechnology company specializing in protein degradation therapeutics, stands at a critical juncture as it approaches the release of pivotal clinical trial data.

With the Canadian economy experiencing a contraction in November and a recent interest rate cut by the Bank of Canada due to tariff uncertainties, investors are navigating a complex landscape. In such ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average wages, with ripple effects across ...